BYAH Park Ha Biological Technology Co., Ltd. Annual reports only
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Nasdaq · SEC CIK 1986247 · Fiscal year ends 10/31
Financial factors as of 2025-10-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY6.0%
TTM net income YoY-5,191.3%
TTM EPS YoY-4,410.4%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR—
Margins
Gross margin94.4%
Operating margin-956.5%
Net margin-965.0%
FCF margin-0.1%
EBITDA margin-952.1%
Returns
ROE-885.8%
ROA-539.3%
ROIC (approx.)-3,273.0%
Asset turnover0.56x
Leverage & solvency
Liabilities / assets32.9%
Debt / equity0.00x
Current ratio2.92x
Interest coverage-588,997.59x
Cash quality & payout
Operating cash flow / net income-0.00x
Accruals ratio-541.2%
Payout ratio—
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-10-31 | FY20242024-10-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.52M | $2.38M |
| Cost of revenue | $142,526 | $195,336 |
| Gross profit | $2.38M | $2.19M |
| R&D expense | $238,184 | $36,714 |
| SG&A expense | $25.48M | $814,857 |
| Operating income | -$24.15M | $793,714 |
| Interest expense | $41 | — |
| Pretax income | -$24.08M | $793,421 |
| Income tax | $280,646 | $314,860 |
| Net income | -$24.36M | $478,561 |
| EBITDA | -$24.04M | $816,400 |
| EPS (basic) | -41.38 | 0.96 |
| EPS (diluted) | -41.38 | 0.96 |
| Weighted avg. shares (diluted) | 588,866 | 500,000 |
| Balance sheet | ||
| Cash & equivalents | $3.79M | $547,498 |
| Receivables | $255,844 | $330,892 |
| Inventory | $75,214 | $71,486 |
| Current assets | $5.50M | $2.84M |
| PP&E, net | $157,999 | $103,960 |
| Intangibles | $6,639 | $7,621 |
| Total assets | $5.95M | $3.08M |
| Current liabilities | $1.88M | $1.52M |
| Total liabilities | $1.96M | $1.58M |
| Shareholders' equity | $3.99M | $1.51M |
| Shares outstanding | — | 25.00M |
| Cash flow statement | ||
| Operating cash flow | $85,852 | $960,470 |
| Capital expenditure | $88,825 | $85,569 |
| Free cash flow | -$2,973 | $874,901 |
| Investing cash flow | -$572,927 | -$508,143 |
| Financing cash flow | $3.74M | -$957,389 |
| Depreciation & amortization | $109,369 | $22,686 |
| Stock-based compensation | $24.07M | — |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.